Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-23
DOI: 10.2147/dddt.s605798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Yang Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, People's Republic of China. Hauptthemen laut MEDLINE: Aspirin, Hearing Loss, Nanotechnology, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, People's Republic of China.
Zitieren
APA
Yang, Y., Tian, C., An, X., Fan, B., & Zha, D. (2026). Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future. Drug Design, Development and Therapy, Volume 20, 1-23. https://doi.org/10.2147/dddt.s605798
Vancouver
Yang Y, Tian C, An X, Fan B, Zha D. Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future. Drug Design, Development and Therapy. 2026;Volume 20:1-23. doi:10.2147/dddt.s605798
BibTeX
@article{Yang2026,
author = {Yang, Yang and Tian, Chaoyong and An, Xiaogang and Fan, Bei and Zha, Dingjun},
title = {Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--23},
doi = {10.2147/dddt.s605798}
}
EUVIMED